To improve health outcomes in developing countries in a meaningful way, pharmaceutical companies must do more than merely provide medicine at reduced prices. Strengthening local capabilities by working with communities and startups and nurturing innovation ecosystems will be critical to mitigating future threats.
PARIS – While the end of the COVID-19 pandemic may be “in sight,” as the World Health Organization recently declared, the world faces numerous emerging health risks. Some are exacerbated by climate change, others by travel, online misinformation, food scarcity, poverty, or wars. Fortunately, the pandemic has taught us valuable lessons for managing these risks – and for helping vulnerable developing economies better prepare for future health crises.
PARIS – While the end of the COVID-19 pandemic may be “in sight,” as the World Health Organization recently declared, the world faces numerous emerging health risks. Some are exacerbated by climate change, others by travel, online misinformation, food scarcity, poverty, or wars. Fortunately, the pandemic has taught us valuable lessons for managing these risks – and for helping vulnerable developing economies better prepare for future health crises.